Tata 1mg revenue nears Rs 2,400 Cr in FY25, trims losses

Tata 1mg, the e-pharmacy and healthcare platform, saw its revenue approach "₹2,400 crore in FY25 while significantly trimming its losses." This financial performance indicates strong growth and improved operational efficiency for the Tata Digital subsidiary. The reduction in losses despite increasing revenue suggests that Tata 1mg is moving closer to profitability, leveraging India's burgeoning digital healthcare market. This positive trend underscores its strategic importance within the Tata Digital ecosystem and its potential to become a leading player in the health-tech sector.